Boom Or Bust: Where Does Applied Therapeutics Inc (NASDAQ: APLT) Stock Go From Here?

During the last session, Applied Therapeutics Inc (NASDAQ:APLT)’s traded shares were 0.43 million, with the beta value of the company hitting 1.92. At the end of the trading day, the stock’s price was $4.28, reflecting an intraday gain of 1.18% or $0.05. The 52-week high for the APLT share is $9.39, that puts it down -119.39 from that peak though still a striking 72.43% gain since the share price plummeted to a 52-week low of $1.18. The company’s market capitalization is $488.95M, and the average trade volume was 1.81 million shares over the past three months.

Applied Therapeutics Inc (NASDAQ:APLT) trade information

Applied Therapeutics Inc (APLT) registered a 1.18% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.18% in intraday trading to $4.28, hitting a weekly high. The stock’s 5-day price performance is -2.28%, and it has moved by -37.52% in 30 days. Based on these gigs, the overall price performance for the year is 181.58%.

Applied Therapeutics Inc (APLT) estimates and forecasts

Statistics show that Applied Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Applied Therapeutics Inc (APLT) shares have gone up 53.96% during the last six months, with a year-to-date growth rate more than the industry average at 62.68% against 12.90. In the rating firms’ projections, revenue will decrease -35.10% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3.33M as predicted by 3 analyst(s).

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -8.72%. While earnings are projected to return 48.77% in 2024.

APLT Dividends

Applied Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders